Securities code: Lanzhou Foci Pharmaceutical Co.Ltd(002644) securities abbreviation: Lanzhou Foci Pharmaceutical Co.Ltd(002644) Announcement No.: 2022004 Lanzhou Foci Pharmaceutical Co.Ltd(002644)
Announcement of resolutions of the 12th meeting of the 7th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Lanzhou Foci Pharmaceutical Co.Ltd(002644) (hereinafter referred to as “the company”) the 12th meeting of the 7th board of supervisors was held in the form of on-site meeting at 11:00 a.m. on March 15, 2022. Mr. Su Wenbo, chairman of the board of supervisors, presided over the meeting. The notice of the meeting will be delivered in writing and by telephone on February 29, 2022. Three supervisors should attend the meeting and three supervisors actually attended the meeting. The meeting was held in accordance with the company law, the articles of association, the rules of procedure of the board of supervisors and relevant laws and regulations.
After deliberation, the attending supervisors passed the following proposals:
1、 The work report of the board of supervisors in 2021 was reviewed and adopted
For details of the work report of the board of supervisors in 2021, see http://www.cn.info.com.cn.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
Voting results: 3 in favor, 0 against and 0 abstention.
2、 Reviewed and adopted the financial final accounts report of 2021
This proposal needs to be submitted to the 2020 annual general meeting of shareholders for deliberation.
Voting results: 3 in favor, 0 against and 0 abstention.
3、 The 2021 profit distribution plan was reviewed and approved
Profit distribution plan for 2021: Based on the total share capital of 510657000 shares as of December 31, 2021, the company will distribute cash dividends of RMB 0.10 (including tax) for every 10 shares to all shareholders, with a total cash distribution of RMB 510657000. No bonus shares will be given and no capital reserve will be converted into share capital.
The profit distribution plan complies with the company law, the articles of association and other relevant provisions.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
There were 0 affirmative votes and 3 abstention votes.
4、 The annual report for 2021 and its summary were reviewed and adopted
The board of supervisors reviewed and agreed the 2021 annual report and report summary, and issued the following concluding comments: the preparation and review procedures of the company’s 2021 annual report and report summary comply with the provisions of the CSRC and Shenzhen Stock Exchange, and the information contained objectively and truly reflects the company’s financial situation and operating results of the current year; The directors, supervisors, senior managers and other secret related personnel of the company strictly abide by the obligation of confidentiality and have not disclosed the contents of the annual report in advance.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
Voting results: 3 in favor, 0 against and 0 abstention.
5、 The 2021 internal control evaluation report was reviewed and adopted
The board of supervisors carefully reviewed the 2021 internal control evaluation report and considered that the 2021 internal control evaluation report objectively reflected the current situation of the company’s internal control. For the major defects in the financial report involved in the internal control report, the board of supervisors will actively urge the board of directors and the management to implement relevant rectification measures, continuously improve corporate governance, prevent business risks, and effectively safeguard the rights and interests of the company and all shareholders.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
Voting results: 3 in favor, 0 against and 0 abstention.
6、 Proposal on correction of previous accounting errors
The board of supervisors believes that the correction of the company’s previous accounting errors complies with the relevant provisions of the accounting standards for Business Enterprises No. 28 – changes in accounting policies and accounting estimates and correction of errors and the preparation rules for information disclosure of companies offering securities to the public No. 19 – correction and related disclosure of financial information, and the corrected financial data and financial statements can be more objective, true and accurate Accurately reflect the operating results of the company. The deliberation and voting procedures of the board of directors on the correction of accounting errors comply with the relevant provisions of laws, administrative regulations and normative documents, and there is no situation that damages the interests of the company and all shareholders. Therefore, the board of supervisors agreed to the correction and retroactive adjustment of accounting errors.
Voting results: 3 in favor, 0 against and 0 abstention.
See http://www.cn.info.com.cn for details of the announcement on correction of accounting errors in the earlier period. 7、 The proposal on confirming the daily connected transactions in 2021 and the expected daily connected transactions in 2022 was reviewed and approved
The board of supervisors believes that the daily related party transactions with related parties in 2021 and the daily related party transactions planned to occur in 2022 confirmed by the company meet the actual production and operation needs of the company, do not affect the independence of the company’s operation, are conducive to the company’s production and operation, do not damage the interests of the company and all shareholders, and have no impact on the independence of the company. The deliberation and decision-making procedures of the company’s connected transactions comply with the relevant provisions of the company law, the securities law and the articles of association.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
Voting results: 3 in favor, 0 against and 0 abstention.
Documents for future reference: resolutions of the 12th meeting of the 7th board of supervisors of the company
It is hereby announced.
Lanzhou Foci Pharmaceutical Co.Ltd(002644) board of supervisors
March 15, 2022
